Odden Michelle C, Amadu Abdul-Razak, Smit Ellen, Lo Lowell, Peralta Carmen A
School of Biological and Population Health Sciences, College of Public Health and Human Sciences, Oregon State University, Corvallis, OR.
School of Biological and Population Health Sciences, College of Public Health and Human Sciences, Oregon State University, Corvallis, OR.
Am J Kidney Dis. 2014 Oct;64(4):550-7. doi: 10.1053/j.ajkd.2014.04.024. Epub 2014 Jun 4.
Chronic kidney disease (CKD) and hyperuricemia often coexist, and both conditions are increasing in prevalence in the United States. However, their shared role in cardiovascular risk remains highly debated.
Cross-sectional and longitudinal.
SETTING & PARTICIPANTS: Participants in the National Health and Nutrition Examination Survey (NHANES) from 1988 to 2002 (n = 10,956); data were linked to mortality data from the National Death Index through December 31, 2006.
Serum uric acid concentration, categorized as the sex-specific lowest (< 25th), middle (25th- < 75th), and highest (≥ 75th) percentiles; and kidney function assessed by estimated glomerular filtration rate (eGFR) based on the CKD-EPI (CKD Epidemiology Collaboration) creatinine-cystatin C equation and urinary albumin-creatinine ratio (ACR).
Cardiovascular death and all-cause mortality.
Uric acid levels were correlated with eGFR(cr-cys) (r = -0.29; P < 0.001) and were correlated only slightly with ACR (r = 0.04; P < 0.001). There were 2,203 deaths up until December 31, 2006, of which 981 were due to cardiovascular causes. Overall, there was a U-shaped association between uric acid levels and cardiovascular mortality in both women and men, although the lowest risk of cardiovascular mortality occurred at a lower level of uric acid for women compared with men. There was an association between the highest quartile of uric acid level and cardiovascular mortality even after adjustment for potential confounders (HR, 1.48; 95% CI, 1.13-1.96), although this association was attenuated after adjustment for ACR and eGFR(cr-cys) (HR, 1.25; 95% CI, 0.89-1.75). The pattern of association between uric acid levels and all-cause mortality was similar.
GFR not measured; mediating events were not observed.
High uric acid level is associated with cardiovascular and all-cause mortality, although this relationship was no longer statistically significant after accounting for kidney function.
慢性肾脏病(CKD)和高尿酸血症常同时存在,且在美国这两种疾病的患病率均在上升。然而,它们在心血管风险中的共同作用仍存在高度争议。
横断面研究和纵向研究。
1988年至2002年美国国家健康与营养检查调查(NHANES)的参与者(n = 10,956);数据与截至2006年12月31日的国家死亡指数的死亡率数据相关联。
血清尿酸浓度,分为按性别划分的最低(<第25百分位数)、中间(第25百分位数至<第75百分位数)和最高(≥第75百分位数)三分位数;以及根据CKD-EPI(慢性肾脏病流行病学协作组)肌酐-胱抑素C方程和尿白蛋白-肌酐比值(ACR)通过估算肾小球滤过率(eGFR)评估的肾功能。
心血管死亡和全因死亡率。
尿酸水平与eGFR(cr-cys)相关(r = -0.29;P < 0.001),与ACR仅轻微相关(r = 0.04;P < 0.001)。截至2006年12月31日有2203例死亡,其中981例死于心血管原因。总体而言,女性和男性的尿酸水平与心血管死亡率之间均呈U形关联,尽管女性心血管死亡率的最低风险发生时的尿酸水平低于男性。即使在调整潜在混杂因素后,尿酸水平最高四分位数与心血管死亡率之间仍存在关联(HR,1.48;95%CI,1.13 - 1.96),尽管在调整ACR和eGFR(cr-cys)后这种关联减弱(HR,1.25;95%CI,0.89 - 1.75)。尿酸水平与全因死亡率之间的关联模式相似。
未测量肾小球滤过率;未观察到介导事件。
高尿酸水平与心血管和全因死亡率相关,尽管在考虑肾功能后这种关系不再具有统计学意义。